{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "PARK7",
                "Protein_Change": {
                    "ref": "M",
                    "alt": "I",
                    "position": "26"
                },
                "variant_string_id": "PARK7 M26I"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss - of - function mutations in the DJ - 1 gene (PARK7) cause autosomal - recessive hereditary Parkinson disease (PD). DJ - 1 protects against oxidative stress and mitochondrial toxins, and its cytoprotective effects may be mediated by molecular chaperoning, and/or facilitation of the pro - survival Akt and suppression of apoptosis signal - regulating kinase 1 (ASK1) pathways. The cytoprotective activity of DJ - 1 against oxidative stress depends on its cysteine residues.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines that PD can be caused by loss - of - function mutations in PARK7, and it details the cytoprotective functions of DJ - 1 and its dependence on cysteine residues in relation to the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used assays such as measuring DJ - 1 protein levels, mRNA levels, protein stability, dimerization, ASK1 co - immunoprecipitations, size exclusion chromatography of the ASK1 complex, ASK1 immune complex kinase assay, measurement of cytotoxicity, and Daxx translocation. These assays are relevant to studying the cytoprotective function of DJ - 1 and its interaction with ASK1, which is related to the disease mechanism of PD.",
                    "judgment": "Yes",
                    "reasoning": "The general classes of assays effectively model the disease pathogenesis as they are designed to study the functions and interactions of DJ - 1 that are known to be involved in PD. For example, the ASK1 - related assays help understand how DJ - 1's normal function is disrupted in the context of PD.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Each experiment was performed independently at least two times. Statistical analysis was performed using analysis of variance with Bonferroni multiple comparisons post - test. Controls were used, for example, in the ASK1 immune complex kinase assay, stable back - transfectant MEF cell lines with vector controls were used. Replicates were also used as cytotoxicity was measured in triplicate samples in LDH release assays.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (such as vector controls) and replicates (e.g., triplicate samples in LDH release assays) were used in the experiments, fulfilling the requirements for this step.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "The study compared the effects of the M26I mutant with wild - type DJ - 1 in multiple assays. While not using known pathogenic or benign variants as controls in the traditional sense, the wild - type DJ - 1 serves as a de - facto control to show the differences in function of the M26I mutant.",
                    "judgment": "Yes",
                    "reasoning": "The use of wild - type DJ - 1 as a control in the experiments meets the criteria of having a variant control for the M26I mutant. This allows for a comparison of the functional differences between the mutant and normal protein.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Each experiment was performed independently at least two times. The results shown in figures are, if not otherwise stated, mean values Â± S.E. of 2 - 4 independent experiments. Statistical analysis was performed using analysis of variance with Bonferroni multiple comparisons post - test using InStat.",
                    "judgment": "Yes",
                    "reasoning": "The paper uses statistical analysis methods such as analysis of variance with Bonferroni multiple comparisons post - test, indicating that there are sufficient statistical analyses to estimate or calculate relevant measures for the functional data of the M26I variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "Although the paper does not explicitly calculate OddsPath, the use of statistical analysis with clear significance levels (e.g., *, p < 0.05; ***, p < 0.001) in assays like LDH release and Daxx translocation assays implies a relatively strong effect of the M26I mutation. Given the significant differences in cytoprotection and Daxx translocation suppression compared to wild - type, it can be inferred that the OddsPath is high.",
                    "judgment": "PS3_very_strong",
                    "reasoning": "Based on the significant differences in functional assays between the M26I mutant and wild - type DJ - 1, it is reasonable to assume that the OddsPath is very high, corresponding to a very strong pathogenic effect as per ACMG guidelines.",
                    "next_step_or_outcome": "Final determination of evidence strength"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_very_strong"
            },
            "overall_conclusion": "The M26I variant in the PARK7 gene was assessed. The disease mechanism of PD due to PARK7 loss - of - function was clearly defined. The assays used were applicable to the disease mechanism. Basic controls and replicates were used, and wild - type DJ - 1 served as a variant control. Sufficient statistical analyses were performed, and based on the significant functional differences compared to wild - type, the functional evidence strength was determined to be PS3_very_strong, indicating a strong pathogenic effect of the M26I variant."
        }
    ]
}